Structure-based Design of Selective metallo-β-lactamase
基于结构的选择性金属-β-内酰胺酶设计
基本信息
- 批准号:18390038
- 负责人:
- 金额:$ 10.63万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:2006
- 资助国家:日本
- 起止时间:2006 至 2007
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Metallo-β-lactamases catalyzes the hydrolysis of most β-lactam antibiotics including carbapenems, and there are currently no potent inhibitors of such enzymes. Our ultimate goal is to develop structure-based inhibitors of metallo-β-lactamases and we set two subthemes :(1)Preparation of apoenzyme of IMP-1 metallo-β-lactamase from Seratia marcescens.The apo-IMP-1 enzyme can be obtained by application of rather high temperature(30℃),high concentration of EDTA(50 mM)and the medium of pH 6.5(MOPS-NaOH, 50 mM, pH 6.5, 1.0 M NaCl containing 30% glycerol).Excess EDTA was removed by use of short gel filtration column (PD-10)at 4℃. The Zn(II)content of the prepared apo-IMP-1 enzyme was checked by atomic absorption spectrometry to be 0.076 per an IMP-1 molecule, indicating that the activity of apo-IMP-1 enzyme is less than 95 % of the untreated EDTA. In apo-IMP-1 prepared by this method, the enzymatic activity was perfectly recovered by the addition of a small excess of Zn(NO_3)_2・6H_2O.(2) Crystallization and crystallographic of VIM-2 metallo-β-lactamase from Pseudomonas aeruginosa Complexed with a Mercaptocarboxylate InhibitorRecently, we found rac-2-Phenylpropyl-3-mercaptopropionic acid, PhenylC3SH, was found to be a potent inhibitor of VIM-2. The structure of the VIM-2-PhenylC3SH complex was determined by X-ray crystallography to 2.3 A. The structure revealed that the thiol group of PhenylC3SH bridged to the two zinc (II) ions and the phenyl group interacted with Tyr67 (47) on loop1 near the active site, by π-π stacking interactions. The methylene group interacted with Phe61 (42) located at the bottom of loop1 though CH-π interactions. Dynamic movements were observed in Arg228 (185) and Asn233 (190) on loop2, compared with the native structure (PDB code: 1KO3). These results suggest that the above-mentioned four residues play important roles in the binding and recognition of inhibitors or substrates and in stabilizing a loop in the VIM-2 enzyme.
金属-β-内酰胺酶催化大多数β-内酰胺抗生素(包括碳青霉烯类)的水解,目前还没有此类酶的有效抑制剂。(1)从粘质沙雷氏菌(Seratiamarcescens)中制备IMP-1金属β-内酰胺酶的脱辅基酶(apo-IMP-1 enzyme),采用高温(30℃)、高浓度EDTA(50 mM)、pH6.5(MOPS-NaOH,50 mM,pH6.5,1.0 M NaCl,含30%甘油)的条件,在4℃下用短凝胶过滤柱(PD-10)除去过量的EDTA,得到apo-IMP-1酶。通过原子吸收光谱法检查制备的apo-IMP-1酶的Zn(II)含量为0.076/IMP-1分子,表明apo-IMP-1酶的活性小于未处理EDTA的95%。在此方法制备的apo-IMP-1中,加入少量过量的Zn(NO_3)_2·6H_2O即可完全恢复酶活性。(2)铜绿假单胞菌Vim-2金属β-内酰胺酶与巯基羧酸抑制剂复合物的结晶和晶体学研究Vim-2-PhenylC 3SH复合物的结构通过X射线晶体学测定为2.3 A。结构分析表明,PhenylC 3SH的巯基与两个Zn(II)离子桥连,苯基与活性中心附近环1上的Tyr 67(47)通过π-π堆积作用相互作用。亚甲基通过CH-π相互作用与位于环1底部的Phe 61(42)相互作用。与天然结构(PDB代码:1 KO 3)相比,在环2上的Arg 228(185)和Asn 233(190)中观察到动态运动。这些结果表明,上述四个残基在结合和识别抑制剂或底物以及稳定Vim-2酶中的环中起重要作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Crystallographic Investigation of the Inhibition Mode of VIM-2 Metallo-β-lactamase from Pseudomonas aeruginosa by a Mercaptocarboxylate Inhibitor
巯基羧酸酯抑制剂对铜绿假单胞菌 VIM-2 金属-β-内酰胺酶抑制模式的晶体学研究
- DOI:
- 发表时间:2007
- 期刊:
- 影响因子:0
- 作者:Yoshihiro;Yamaguchi
- 通讯作者:Yamaguchi
Crystallographic investigation of the inhibition mode of a VIM-2 metallo-β-lactamase from Pseudomonas aeruginosa by a mercaptocarboxylate inhibitor
- DOI:10.1021/jm701031n
- 发表时间:2007-12-27
- 期刊:
- 影响因子:7.3
- 作者:Yamaguchi, Yoshihiro;Jin, Wanchun;Kurosaki, Hiromasa
- 通讯作者:Kurosaki, Hiromasa
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KUROSAKI Hiromasa其他文献
KUROSAKI Hiromasa的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KUROSAKI Hiromasa', 18)}}的其他基金
Development of inhibitors based on the molecular structure and mechanism of substrate hydrolysis by metallo-beta-lactamases
基于金属-β-内酰胺酶底物水解的分子结构和机制开发抑制剂
- 批准号:
26460147 - 财政年份:2014
- 资助金额:
$ 10.63万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of fluorescent probes for metallo-beta-lactamase-producing Gram-negative bacteria
产金属-β-内酰胺酶革兰氏阴性菌荧光探针的开发
- 批准号:
24659054 - 财政年份:2012
- 资助金额:
$ 10.63万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Development of irreversible inhibitors forβ-lactam inactived enzyme, metallo-β-lactamase
β-内酰胺失活酶、金属-β-内酰胺酶不可逆抑制剂的开发
- 批准号:
21590116 - 财政年份:2009
- 资助金额:
$ 10.63万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of functional molecules capable of recognizing and cleaving the bulge structure in DNA by using an optical active dinuclear iron complex
利用光学活性双核铁络合物开发能够识别和切割 DNA 凸起结构的功能分子
- 批准号:
16590031 - 财政年份:2004
- 资助金额:
$ 10.63万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Sequence specific double-strand DNA cleavage by an optical active dinuclear iron complex and application for artificial restriction enzyme
光学活性双核铁复合物对序列特异性双链 DNA 的切割及其人工限制性内切酶的应用
- 批准号:
14572034 - 财政年份:2002
- 资助金额:
$ 10.63万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Project 3: In vitro modeling to define mechanisms of childhood vaccine response, susceptibility to respiratory infectious disease and asthma
项目 3:体外建模以确定儿童疫苗反应、呼吸道传染病和哮喘易感性机制
- 批准号:
10589826 - 财政年份:2022
- 资助金额:
$ 10.63万 - 项目类别:
Project 3: In vitro modeling to define mechanisms of childhood vaccine response, susceptibility to respiratory infectious disease and asthma
项目 3:体外建模以确定儿童疫苗反应、呼吸道传染病和哮喘易感性机制
- 批准号:
10435043 - 财政年份:2022
- 资助金额:
$ 10.63万 - 项目类别:
Discovering new compounds to treat global infectious disease
发现治疗全球传染病的新化合物
- 批准号:
8627185 - 财政年份:2013
- 资助金额:
$ 10.63万 - 项目类别:
Discovering new compounds to treat global infectious disease
发现治疗全球传染病的新化合物
- 批准号:
8443165 - 财政年份:2013
- 资助金额:
$ 10.63万 - 项目类别:
Discovering new compounds to treat global infectious disease
发现治疗全球传染病的新化合物
- 批准号:
9100871 - 财政年份:2013
- 资助金额:
$ 10.63万 - 项目类别:
Discovering new compounds to treat global infectious disease
发现治疗全球传染病的新化合物
- 批准号:
8878462 - 财政年份:2013
- 资助金额:
$ 10.63万 - 项目类别:
Mouse modeling of a human STING gene variant for infectious disease
人类 STING 基因变体感染性疾病的小鼠模型
- 批准号:
8282484 - 财政年份:2012
- 资助金额:
$ 10.63万 - 项目类别:
Mouse modeling of a human STING gene variant for infectious disease
人类 STING 基因变体感染性疾病的小鼠模型
- 批准号:
8519291 - 财政年份:2012
- 资助金额:
$ 10.63万 - 项目类别:
The role for Notch signaling in inflammatory responses in infectious disease
Notch 信号在传染病炎症反应中的作用
- 批准号:
7935983 - 财政年份:2012
- 资助金额:
$ 10.63万 - 项目类别:
STRUCTURAL STUDIES OF THERAPEUTIC TARGETS IN ONCOLOGY AND INFECTIOUS DISEASE
肿瘤学和传染病治疗靶点的结构研究
- 批准号:
8170680 - 财政年份:2010
- 资助金额:
$ 10.63万 - 项目类别:














{{item.name}}会员




